LLY

Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight

02/24 07:00 am

Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making.

02/23 09:30 pm

Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short

02/23 06:21 pm

1 Reason I'd Buy Veeva Systems Stock and Never Sell

02/23 05:37 pm

Viking Therapeutics Stock Gains Amid Obesity Drug Buzz

02/23 03:29 pm

Novo Nordisk Trades at 11x Earnings as GLP-1 Reset Tests Long-Term Thesis

02/23 02:22 pm

Novo Nordisk's Loss Is Eli Lilly's Gain

02/23 12:42 pm

Novo Nordisk Tumbles in 'Worst Case Scenario': Next-Gen Weight Loss Drug Underperforms

02/23 12:35 pm

Eli Lilly: The Weight‑Loss and Diabetes Powerhouse I'd Hold Through Any Market Crash

02/23 11:30 am

1 Reason I'm Seriously Considering Novo Nordisk as a Buy‑and‑Never‑Sell Obesity Stock

02/23 08:18 am

Novo Nordisk Stock Hits 52-Week Low After Weight-Loss Drug Falls Short Against Eli Lilly's

02/23 06:31 am

3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds

02/23 06:10 am

Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036?

02/22 07:30 pm

The Stock Market Just Did This for the First Time in Nearly a Year. History is Strikingly Clear About What Happens Next.

02/21 05:15 am

Novo Nordisk Stock Investors Just Got Great News From Eli Lilly

02/20 09:15 pm

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

02/20 02:15 pm

Eli Lilly Breaks New Ground In Crohn's Disease Treatment

02/20 08:23 am

Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies

02/20 06:53 am

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing

02/20 01:02 am

Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo

02/18 01:51 pm

Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - Opportunities in Surge in Merger & Acquisitions, Increasing R&D Investments

02/18 08:00 am

Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

02/18 06:55 am

2026 Could Be a Big Year for Viking Therapeutics. Time to Buy?

02/17 09:15 am

Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients

02/17 07:42 am

Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline

02/16 09:00 am

What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?

02/14 03:25 pm

CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens

02/13 02:45 pm

Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?

02/13 11:15 am

Meet the 6.3% Yield Dividend Stock That Could Soar in 2026

02/13 07:32 am

Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms

02/13 06:36 am

Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market

02/12 02:02 pm

Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.

02/12 06:10 am

I Predicted That ExxonMobil Would Join the $1 Trillion Club by 2030, But the Stock Is Already Up 24% in 2026. Is the High-Yield Dividend Stock Still a Buy Now?

02/11 09:05 pm

3 Reasons to Buy Eli Lilly Stock

02/11 12:15 pm

Disney Has Its Next CEO

02/11 11:30 am

Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore

02/11 02:15 am

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

02/10 09:11 pm

FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds

02/10 10:00 am

Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?

02/09 03:30 pm

Over 60% of Eli Lilly's Revenue Comes From Its GLP-1 Drugs. Should Investors Be Worried?

02/09 12:30 pm

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

02/09 12:00 pm

Eli Lilly Bets $2.4 Billion On Small Biotech To Boost Future Cell Treatments

02/09 10:11 am

Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock?

02/08 12:05 pm

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

02/07 10:30 pm

3 Things Investors Need to Know About the Healthcare Sector in 2026

02/07 10:13 am

Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore

02/06 03:15 pm

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

02/06 02:52 pm

Why Shares of Novo Nordisk Stock Collapsed This Week

02/06 12:31 pm

Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

02/06 06:00 am

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.

02/05 09:15 pm